Skip to main content
. 2021 Apr 22;17(11):e1719–e1727. doi: 10.1200/OP.20.00569

FIG 1.

FIG 1.

Outcomes of community oncologists' use of EA and Right To Try pathways. (A) Individual patient EA IND, (B) treatment protocol IND, and (C) Right To Try. EA, expanded access; FDA, US Food and Drug Administration; IND, Investigation New Drug application.